Yamamoto K - Search Results

1

Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients.

Ohkawa K, Hayashi N, Yuki N, Hagiwara H, Kato M, Yamamoto K, Eguchi H, Fusamoto H, Masuzawa M, Kamada T. Ohkawa K, et al. Among authors: yamamoto k. J Hepatol. 1994 Oct;21(4):509-14. doi: 10.1016/s0168-8278(94)80094-4. J Hepatol. 1994. PMID: 7529271

2

Long-term clinical impact of occult hepatitis B virus infection in chronic hepatitis B patients.

Komori M, Yuki N, Nagaoka T, Yamashiro M, Mochizuki K, Kaneko A, Yamamoto K, Hikiji K, Kato M. Komori M, et al. Among authors: yamamoto k. J Hepatol. 2001 Dec;35(6):798-804. doi: 10.1016/s0168-8278(01)00214-8. J Hepatol. 2001. PMID: 11738108

3

[Two-step interferon rebound therapy for refractory chronic hepatitis C].

Kato M, Yuki N, Kaneko A, Yamamoto K, Kasahara A, Masuzawa M, Hayashi N. Kato M, et al. Among authors: yamamoto k. Nihon Rinsho. 2001 Jul;59(7):1315-9. Nihon Rinsho. 2001. PMID: 11494544 Review. Japanese.

4

Long-term follow-up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses.

Ohkawa K, Hayashi N, Yuki N, Masuzawa M, Kato M, Yamamoto K, Hosotsubo H, Deguchi M, Katayama K, Kasahara A, et al. Ohkawa K, et al. Among authors: yamamoto k. J Med Virol. 1995 Jul;46(3):258-64. doi: 10.1002/jmv.1890460316. J Med Virol. 1995. PMID: 7561800

5

Retreatment with interferon for chronic hepatitis C after transient response.

Iyoda K, Yuki N, Kato M, Sugiyasu Y, Komori M, Fujii E, Kakiuchi Y, Kaneko A, Yamamoto K, Kurosawa K, Ikeda M, Masuzawa M. Iyoda K, et al. Among authors: yamamoto k. J Clin Gastroenterol. 2000 Dec;31(4):297-301. doi: 10.1097/00004836-200012000-00006. J Clin Gastroenterol. 2000. PMID: 11129270 Clinical Trial.

6

Thrombotic thrombocytopenic purpura developed suddenly during interferon treatment for chronic hepatitis C.

Iyoda K, Kato M, Nakagawa T, Kakiuchi Y, Sugiyasu Y, Fujii E, Fujimoto K, Michida T, Kaneko A, Hayashi N, Yamamoto K, Kurosawa K, Ikeda M, Masuzawa M. Iyoda K, et al. Among authors: yamamoto k. J Gastroenterol. 1998 Aug;33(4):588-92. doi: 10.1007/s005350050139. J Gastroenterol. 1998. PMID: 9719249

7

Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization.

Yamamoto K, Masuzawa M, Kato M, Okuyama T, Tamura K. Yamamoto K, et al. Cancer Chemother Pharmacol. 1992;31 Suppl:S77-81. doi: 10.1007/BF00687111. Cancer Chemother Pharmacol. 1992. PMID: 1281047

8

Use of a new embolic and sclerotic agent (GT-XIII) in endoscopic sclerotherapy.

Terada A, Miyoshi E, Yamamoto K, Katoh M, Masuzawa M, Tamura K, Fukui O, Abe H, Sugitachi A. Terada A, et al. Among authors: yamamoto k. J Gastroenterol Hepatol. 1989;4 Suppl 1:181-3. J Gastroenterol Hepatol. 1989. PMID: 2519046 No abstract available.

9

Analysis of nucleotide sequences of hepatitis C virus isolates from husband-wife pairs.

Setoguchi Y, Kajihara S, Hara T, Motomura M, Mizuta T, Wada I, Yamamoto K, Sakai T. Setoguchi Y, et al. Among authors: yamamoto k. J Gastroenterol Hepatol. 1994 Sep-Oct;9(5):468-71. doi: 10.1111/j.1440-1746.1994.tb01276.x. J Gastroenterol Hepatol. 1994. PMID: 7530061

10

Histologic activity of the liver in children with transfusion-associated chronic hepatitis C.

Inui A, Fujisawa T, Miyagawa Y, Sekine I, Hanada R, Yamamoto K, Shiihara H, Inui M. Inui A, et al. Among authors: yamamoto k. J Hepatol. 1994 Nov;21(5):748-53. doi: 10.1016/s0168-8278(94)80234-3. J Hepatol. 1994. PMID: 7890889

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,601 results

Search Page

Filters